Strict management of secondary hyperparathyroidism may be necessary to improve prognosis in patients on dialysis who have coronary artery disease requiring percutaneous coronary intervention. High ...

Please provide your email address to receive an email when new articles are posted on . At 52 weeks, 81% of adults receiving palopegteriparatide had normalized serum calcium levels without needing ...

Blanket routine calcium supplementation after thyroidectomy was no more effective than selective, parathyroid hormone (PTH)-guided therapy for preventing hypocalcemia in a randomized trial. The ...

Serum levels of phosphate and parathyroid hormone are lower early in the day and higher late in the day, recently reported data suggest. Phosphate and parathyroid hormone (PTH) levels at the start of ...

PHOENIX — Recombinant human parathyroid hormone (PTH) given subcutaneously improved mineral homeostasis and was well tolerated in a 24-week phase 3 clinical trial of 134 adult patients with ...

Researchers led by Prof. YANG Fan from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences and their collaborators have proposed a new approach to control ...

Credit: Getty Images. The phase 3 PaTHway trial included 82 adults with chronic hypoparathyroidism. Positive topline results were announced from a phase 3 trial evaluating the efficacy and safety of ...

The knee meniscus is an important tissue that protects the joint; if the meniscus is damaged—by sports injury or aging–it often does not heal on its own. There are two surgical methods for treating a ...

It’s been a long wait for Ascendis Pharma to score FDA approval for its hormone replacement therapy TransCon PTH (palopegteriparatide). And, now, it’ll take another three months for the U.S. regulator ...

Please provide your email address to receive an email when new articles are posted on . Most adults with hypoparathyroidism no longer need vitamin D or calcium supplementation with palopegteriparatide ...